The value of CA 125 serum assay in the management of ovarian cancer

This publication has 11 references indexed in Scilit:

• The clinical significance of pre-operative serum CA 125 in ovarian cancer
  BJOG: An International Journal of Obstetrics and Gynaecology, 1987
• Serum CA 125 levels in epithelial ovarian cancer: relation with findings at second‐look operations and their role in the detection of tumour recurrence
  BJOG: An International Journal of Obstetrics and Gynaecology, 1987
• Serum CA 125 in epithelial ovarian cancer. A longitudinal study
  BJOG: An International Journal of Obstetrics and Gynaecology, 1987
• A new immunoassay using monoclonal antibodies HMFG1 and HMFG2 together with an existing marker CA125 for the serological detection and management of epithelial ovarian cancer
  British Journal of Cancer, 1986
• CA 125 Serum Levels Correlated With Second-Look Operations Among Ovarian Cancer Patients
  Obstetrics & Gynecology, 1986
• The value of the monoclonal antibody (cancer antigen 125) in serial monitoring of ovarian cancer: a comparison with circulating immune complexes
  BJOG: An International Journal of Obstetrics and Gynaecology, 1985
• Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker
  British Journal of Cancer, 1984
• A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
  New England Journal of Medicine, 1983
• TARGETING OF IODINE-123-LABELLED TUMOUR-ASSOCIATED MONOCLONAL ANTIBODIES TO OVARIAN, BREAST, AND GASTROINTESTINAL TUMOURS
  The Lancet, 1982
• Continuous cultures of fused cells secreting antibody of predefined specificity
  Nature, 1975